Drug Type Synthetic peptide, Recombinant polypeptide |
Synonyms- |
Target |
Mechanism LRP1 antagonists(LDL receptor related protein 1 antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | - | - | 08 Mar 2023 |